The association of multiple novel and known mutations in the LPL gene can cause severe chylomicronaemia syndrome that is resistant to standard dietary therapy.
Answers are grounded in this paper and cite their sources.
Multiple LPL defects may underlie diet-refractory chylomicronaemia; hypothesis-generating and extends mutational spectrum.
UNLABELLED: The case is reported of a 4-y-old boy with chylomicronaemia syndrome, under treatment with a low-fat diet and medium-chain triglycerides. The clinical and biochemical characteristics of the patient and 11 members of his family were studied. Lipoprotein profile, lipoprotein lipase (LPL) mass and activity were evaluated. Nucleotide substitutions in LPL promoter and exons were screened. The proband presented with severe hypertriglyceridaemia (triglycerides = 13.25 mmol l(-1)) and non-detectable LPL activity and mass. The boy was a compound heterozygote for four molecular defects in the LPL gene, two of which have not been reported before (CGT764 CTT/Arg170 --> Leu; GGA1482 --> GGT/Gly409 --> Gly). Among the family members, the proband was the only one who carried two genetic variants that modify LPL amino acid composition. CONCLUSION: The association of different alterations in the LPL gene could be a key factor in causing the severe phenotype observed. Moreover, treatment with a low-fat diet and medium-chain triglycerides failed to normalize the patient's hypertriglyceridaemia.
No takes yet. Share an insight, caveat, or question.
Brites et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: